Indeed, we further identified patients with anti-PD-1-resistant melanoma to exhibit elevated HSP70 plasma levels as well as an increase in the myeloid-associated genes, CD33, CD11B, CXCR2, S100A8, and S100A9, in tumor tissue specimens relative to responders [54]. This evidence concerns the gene CXCR2 and melanoma.